Cochlear has downgraded its full-year profit guidance, saying the Wuhman coronavirus has cut demand for hearing implant surgery.
Cochlear now expects to earn $270 million to $290 million in 2019/20, up two to nine per cent from what it made in 2018/2019 but down from the $290 million to $300 million previously forecast.
Cochlear shares were down 4.6 per cent to a two-week low of $233.50 at 1016 AEDT.
AAP
Be the first to comment